Riccardi Alice, Puthenparampil Marco, Rinaldi Francesca, Ermani Mario, Perini Paola, Gallo Paolo
Multiple Sclerosis Centre, Department of Neurosciences DNS, Padova, Italy.
Multiple Sclerosis Centre, University Hospital-Medical School, Padova, Italy.
Front Psychol. 2019 Jan 24;10:49. doi: 10.3389/fpsyg.2019.00049. eCollection 2019.
The Brief Repeatable Battery of Neuropsychological Test (BRB-NT) does not explore the executive functions. We combined BRB-NT and Delis-Kaplan Executive Function System Sorting Test (D-KEFS ST) to obtain a more comprehensive evaluation of cognitive impairment in Multiple Sclerosis (MS) patients. 137 Relapsing Remitting MS (RRMS) patients underwent a detailed neuropsychological assessment including BRB-NT, D-KEFS ST and self-administrated questionnaires, namely the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ), the Fatigue Severity Scale (FSS) and the Beck Depression Inventory-Second Edition (BDI-II). Fifty-four patients (39.4%) had normal scores in each item of both batteries (cognitive normal), while 64 patients (46.7%) failed in at least one test of BRB-NT but not of D-KEFS ST (BRB-NT impaired) and 18 (13.1%) failed in at least one test of both batteries (BRB-NT+D-KEFS ST impaired). Only one patient (0.7%) failed in D-KEFS ST, but not in BRB-NT and was excluded from further analysis. BRB-NT+D-KEFS ST impaired patients had a significant higher mean disease duration and median EDSS score (15.5 ± 13.6 years and 3.5, respectively) compared to those with only BRB-NT impaired (7.9 ± 9.2, < 0.01 and 2.5, < 0.05) and with cognitive normal patients (6.7 ± 9.4, < 0.005 and 2.0, < 0.01). SDMT was more frequently impaired in BRB-NT+D-KEFS ST impaired patients (77.8%) compared to only BRB-NT impaired ones (20.0%, < 0.001). The failure in D-KEFS ST was associated with the number of failed BRB-NT items (OR 1.46, IC95% 1.07-1.99, < 0.05) and with pathological SDMT -value (OR 10.56, IC95% 2.50-44.66, < 0.005). Compared to BRB-NT impaired patients and the cognitive normal ones, BRB-NT+D-KEFS ST impaired patients had significant higher MSNQ ( < 0.01) and BDI-II ( < 0.05) values. D-KEFS ST did not increase the number of cognitively impaired MS patients identified by BRB-NT, but provided a more comprehensive evaluation of cognitive decline. D-KEFS ST identified a subgroup of patients with increased self-perception of cognitive decline, depression and higher physical disability.
简短可重复神经心理测验电池(BRB-NT)未对执行功能进行评估。我们将BRB-NT与德利-卡普兰执行功能系统分类测验(D-KEFS ST)相结合,以更全面地评估多发性硬化症(MS)患者的认知障碍。137例复发缓解型MS(RRMS)患者接受了详细的神经心理评估,包括BRB-NT、D-KEFS ST以及自我管理问卷,即多发性硬化症神经心理问卷(MSNQ)、疲劳严重程度量表(FSS)和贝克抑郁量表第二版(BDI-II)。54例患者(39.4%)在两个测验电池的各项中得分均正常(认知正常),而64例患者(46.7%)在BRB-NT的至少一项测验中未通过,但D-KEFS ST的测验均通过(BRB-NT受损),18例患者(13.1%)在两个测验电池的至少一项测验中未通过(BRB-NT+D-KEFS ST受损)。仅1例患者(0.7%)在D-KEFS ST中未通过,但BRB-NT通过,该患者被排除在进一步分析之外。与仅BRB-NT受损患者(7.9±9.2,<0.01和2.5,<0.05)以及认知正常患者(6.7±9.4,<0.005和2.0,<0.01)相比,BRB-NT+D-KEFS ST受损患者的平均病程显著更长,EDSS评分中位数更高(分别为15.5±13.6年和3.5)。与仅BRB-NT受损患者(20.0%,<0.001)相比,BRB-NT+D-KEFS ST受损患者中符号数字模式测验(SDMT)受损更为常见(77.8%)。D-KEFS ST未通过与BRB-NT未通过项目数相关(比值比1.46,95%置信区间1.07-1.99,<0.05),也与SDMT病理值相关(比值比10.56,95%置信区间2.50-44.66,<0.005)。与BRB-NT受损患者和认知正常患者相比,BRB-NT+D-KEFS ST受损患者的MSNQ值(<0.01)和BDI-II值(<0.05)显著更高。D-KEFS ST并未增加BRB-NT所识别出的认知受损MS患者数量,但能更全面地评估认知衰退。D-KEFS ST识别出了一组自我认知的认知衰退、抑郁和身体残疾程度更高的患者亚组。